Maternal infection, cytokines, and risk for schizophrenia

Neuropsychiatric Disorders and Infection

Volumn , Issue , 2005, Pages 96-106

  Gilmore, John H ^a   Jarskog, L Fredrik ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21344452631     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (168)

1. Mortensen PB, Pedersen CB, Westergaard T et al. Effects of family history and season of birth on the risk of schizophrenia. N Engl J Med 1999; 340: 603-8.
2. McGrath J, Murray R. Risk factors for schizophrenia. In: Schizophrenia (Hirsh SR, Weinberger DR, eds). Cambridge MA: Blackwell Science, 1995: 196-9.
3. Bagalkote H, Pang D, Jones PB. Maternal influenza and schizophrenia in offspring. Inti J Ment Health 2001; 39: 3-21.
4. Watson CG, Kucala T, Tilleskjor C, Jacobs L. Schizophrenic birth seasonality in relation to the incidence of infectious diseases and temperature extremes. Arch Gen Psychiatry 1984; 41:85-90.
5. Torrey EF, Rawlings R, Waldman IN. Schizophrenic births and viral diseases in two states. Schizophr Res 1988; 1: 73-7.
6. O’Callaghan E, Sham PC, Talei N et al. The relationship of schizophrenic births to 16 infectious diseases. Br J Psychiatry 1994;165:353-6.
7. Brown AS, Schaefer CA, Wyatt RJ et al. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull 2000; 26:287-95.
8. Brown AS, Begg M, Gravenstein S et al. Serologic evidence for prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004; 61: 774-80.
9. Brown AS, Cohen P, Greenwald S, Susser E. Nonaffective psychosis after exposure to rubella. Am J Psychiatry 2000; 157: 438-43.
10. Suvisaari J, Haukka J, Tanskanen A et al. Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 1999; 156: 1100-2.
11. Buka SL, Tsuang MT, Torrey EF et al. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 2001; 58: 1032-7.
12. Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of birth in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 1997; 28: 1-38.
13. Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: a meta-analysis. Br J Psychiatry 1995; 167: 786-93.
14. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 2000; 159: 1080-92.
15. Greci LS, Gilson GJ, Nevils R et al. Is amniotic fluid analysis the key to preterm labor? A model using interleukin-6 for predicting rapid delivery. Am J Obstet Gynecol 1998; 179: 172-8.
16. Gibbs RS, Romero R, Hillie SL et al. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166:1515-28.
17. Arntzen KJ, Kjollesdal AM, Halgunset J et al. TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 1998; 26: 17-26.
18. Beckmann I, Meisel-Mikolajczyk F, Leszczynski P et al. Endotoxin-induced fetal growth retardation in the pregnant guinea pig. Am J Obstet Gynecol 1993; 168: 714-8.
19. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997; 278: 207-11.
20. Hsu CD, Witter FR. Urogenital infection in preeclampsia. Int J Gynecol Obstet 1995; 49: 271-5.
21. Jones PB, Rantakallio P, Hartikainen A et al. Schizophrenia as a long term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 North Finland general population birth cohort. Am J Psychiatry 1998; 155: 355-64.
22. Dalman C, Allebeck P, Cullberg J et al. Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch Gen Psychiatry 1999; 56: 234-40.
23. Niswander KR, Gordon M. The Women and Their Pregnancies: The Collaborative Perinatal Study of the National Institute of Neurological Diseases and Stroke. Philadelphia: WB Sanders Co, 1972.
24. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy 1. Univariate analysis of risk. Am J Dis Childhood 1985; 139: 1031-8.
25. Gibbs RS, Duff P. Progress in the management of clinical intraamniotic infection. Am J Obstet Gynecol 1991; 164: 1317-26.
26. Rantakallio P, Von Wendt L. Risk factors for mental retardation. Arch Disease Childhood 1985; 60: 946-52.
27. Ciaranello AL, Ciaranello RD. The neurobiology of autism. Ann Rev Neurosci 1995; 18: 101-28.
28. Dobyns WB, Elias ER, Newlin AC et al. Causal heterogeneity in isolated lissencephaly. Neurology 1992; 42: 1375-88.
29. Lynberg MC, Khoury MJ, Lu X, Cocian T. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am J Epidemiol 1994; 140: 244-55.
30. Holst K, Andersen E, Philip J, Henningsen I. Antenatal and perinatal conditions correlated to handicap among 4-year-old children. Am J Perinatology 1989; 6: 258-67.
31. Gilmore JH, Jarskog LF. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 1997; 24: 365-36.
32. Yolken RH, Torrey EF. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995; 8: 131-45.
33. Wright P, Gill M, Murray RM. Schizophrenia: genetics and the maternal immune response to viral infection. Am J Med Genet (Neuropsychiatrie Genet) 1993; 48: 40-6.
34. Ruben FL, Winkelstein A, Sabbagha RE. In utero sensitization with influenza virus in man. Proc Soc Exp Biol Med 1975; 149: 881-3.
35. 2). Am J Obstet Gynecol 1981;141:443-7.
36. Conover PT, Roessmann U. Malformation complex in an infant with intrauterine influenza viral infection. Arch Pathol Lab Med 1990; 114: 535-8.
37. Monif GRG, Sowards DL, Eitzman DV. Serologic and immunologic evaluation of neonates following maternal influenza during the second and third trimesters of gestation. Am J Obstet Gynecol 1972; 114: 239-242.
38. Ramphal R, Donnelly WH, Small PA Jr. Fatal influenza pneumonia in pregnancy: failure to demonstrate transplacental transmission of influenza virus. Am J Obstet Gynecol 1980; 138: 347-8.
39. Irving WL, James DK, Stephenson T et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. Br J Obstet Gynecol 2000;107: 1282-9.
40. Peschke T, Bender A, Nain M, Gemsa D. Role of macrophage cytokines in influenza A virus infections. Immunobiol 1993; 189: 340-55.
41. Conn CA, McClellan JL, Maassab HF et al. Cytokines and the acute phase response to influenza in mice. Am J Physiol 1995; 268: R78-84.
42. Kragsbjerg P, Jones I, Vikerfors T, Hoimberg H. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax 1995; 50: 1253-7.
43. Bartfai T, Schultzberg M. Cytokines in neuronal cell types. Neurochem Int 1993; 22: 435-44.
44. Hopkins SJ, Rothwell NJ. Cytokines and the nervous system I: expression and recognition. Trends Neurosci 1995; 18: 83-8.
45. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of actions. Trends Neurosci 1995; 18: 130-6.
46. Merrill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 1992; 14: 1-10.
47. Mehler MF, Kessler JA. Growth factor regulation of neuronal development. Dev Neurosci 1994; 16: 180-95.
48. Mehler MF, Kessler JA. Hematolymphopoetic and inflammatory cytokines in neural development. Trends Neurosci 1997; 20:357-65.
49. Burns TM, Clough JA, Klein RM et al. Developmental regulation of cytokine expression in the mouse brain. Growth Factors 1993; 9: 253-8.
50. Gadient RA, Otten U. Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNA in rat hypothalamus. Neurosci Lett 1993; 153: 13-6.
51. Gadient RA, Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 1994; 637: 10-4.
52. Pousset F. Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system. Dev Brain Res 1994; 81: 143-6.
53. Mousa A, Seiger A, Kjaeldgaard A, Bakhiet M. Human first trimester forebrain cells express genes for inflammatory and anti-inflammatory cytokines. Cytokine 1999; 11: 55-60.
54. Dziegielewska KM, Moller JE, Potter AM et al. Acute-phase cytokines IL-ip and TNF-a in brain development. Cell Tissue Res 2000; 299: 335-45.
55. Medlock ES, Kaplan DL, Cecchini M et al. Granulocyte-stimulating factor crosses the placenta and stimulates fetal granulopoiesis. Blood 1993; 81: 916-22.
56. Letterio JJ, Geiser AG, Kulkarni AB et al. Maternal rescue of transforming growth factor-pl null mice. Science 1994; 264: 36-8.
57. Stallmach T, Karolyi L. Augmentation of fetal granulopoiesis with chorioamnionitis during the second trimester of gestation. Hum Pathol 1994; 25: 244-7.
58. Li Y, Ohls RK, Rosa C et al. Maternal and umbilical serum concentrations of granulocyte colony-stimulating factor and its messenger RNA during clinical chorioamnionitis. Obstet Gynecol 1995; 86: 428-32.
59. Kent ASH, Sullivan MHF, Elder MG. Transfer of cytokines through human fetal membranes. Reprod Fertility 1994; 100: 81-4.
60. McDuffie RS, Dabies JK, Leslie KK et al. A randomized control trial of interleukin-1 receptor antagonist in a rabbit model of ascending infection in pregnancy. Infec Dis Obstet Gynecol 2001; 9: 233-7.
61. Fortunato SJ, Menon RP, Swan KF, Menon R. Inflammatory cytokines (interleukins 1,6,8 and tumor necrosis factor-a) release from cultured fetal membranes in response to endo-toxic lipopolysaccharide mirrors amniotic fluid. Am J Obstet Gynecol 1996; 174: 1855-62.
62. Taniguchi T, Matsuzaki N, Kameda T et al. The enhanced production of placental interleukin-1 during labor and intrauterine infection. Am J Obstet Gynecol 1991; 165: 131-7.
63. Menon R, Swan KF, Lyden TW et al. Expression of inflammatory cytokines (interleukin-ip and interleukin-6) in amnio-chorionic membranes. Am J Obstet Gynecol 1995; 172: 493-500.
64. Gomez R, Romero R, Ghezzi F et al. The fetal inflammatory syndrome. Am J Obstet Gynecol 1998; 179: 194-202.
65. Yoon BH, Romero R, Moon J et al. Differences in the fetal interleukin-6 response to microbial invasion of the amniotic cavity between term and preterm gestation. Maternal-Fetal Neonatal Med 2003; 13: 32-8.
66. Banks WA, Kastin AJ, Durham DA. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull 1989; 23:433-7.
67. Banks WA, Ortiz L, Plotkin SR, Kastin AJ. Human interleukin (IL) la, murine IL-la and murine IL-lp are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Therapeutics 1991; 259: 988-96.
68. Guiterrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993; 47: 169-76.
69. Guiterrez EG, Banks WA, Kastin AJ. Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J Neuroimmunol 1994;55: 153-60.
70. Banks WA, Kastin AJ, Guiterrez EG. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 1994; 179: 53-6.
71. de Vries HE, Blom-Roosemalen MCM, van Oosten M et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Immunol 1996; 64: 37-43.
72. Quagliarello VJ, Wispelwey B, Long WJ Jr, Scheld WM. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Investigation 1991; 87: 1360-5.
73. Adinolfi A, Beck SE, Haddad SA, Seller MJ. Permeability of the blood-cerebrospinal fluid barrier to plasma proteins during foetal and perinatal life. Nature 1976; 259: 140-1.
74. Adinolfi A. The development of the human blood-CSF-brain barrier. Dev Med Child Neurol 1985; 27: 532-7.
75. Buka SL, Tsuang MT, Torrey EF et al. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immunity 2001; 15:411-20.
76. Boin F, Zanardini R, Pioli R. Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 2001; 6: 79-82.
77. Jun T-Y, Pae C-U, Chae J-H et al. TNFB polymorphism may be associated with schizophrenia in the Korean population. Schizophr Res 2003; 61: 39-45.
78. Meira-Lima IV, Pereira AC, Mota GF et al. Analysis of a polymorphism of the promoter region of the tumor necrosis factor alpha gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia. Mol Psychiatry 2003;8:718-20.
79. Katila H, Hanninen K, Hurme M. Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 1999; 4: 179-81.
80. Meisenzahl EM, Rujescu D, Kirner A et al. Association of an IL-1/3 genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry 2001; 158: 1316-9.
81. Wassink TH, Crowe RR, Andreasen NC. Tumor necrosis factor receptor-II: heritability and effect on brain morphology in schizophrenia. Mol Psychiatry 2000; 5: 678-82.
82. Roberts AK, Monzon-Bordonada F, Van Deerlin PG et al. Association of a polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm rupture of the fetal membranes. Am J Obstet Gynecol 1999; 180: 1297-302.
83. Aidoo M, McElroy PD, Kolczak MS et al. Tumor necrosis factor-a variant 2(TNF2) is associated with preterm delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay cohort project IX. Genet Epidemiol 2001; 21: 201-11.
84. Saito S, Kasahara T, Kato Y et al. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8, and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993; 5: 81-8.
85. Stallmach T, Hebisch G, Joller-Jemelka HI et al. Cytokine production and visualized effects in the feto-maternal unit: quantitative and topographic data on cytokines during intrauterine disease. Laboratory Investigation 1995; 73: 384-92.
86. Romero R, Brody DT, Oyarzun E et al. Infection and labor III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989; 160: 1117-23.
87. Romero R, Manogue KR, Mitchell MD et al. Infection and labor IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989; 161: 336-41.
88. Miller LC, Isa S, LoPreste G et al. Neonatal interleukin-l{3, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production. J Pediatrics 1990; 117: 961-5.
89. Lencki SG, Maciulla MB, Eglinton GS. Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis. Am J Obstet Gynecol 1994; 170: 1345-51.
90. Salafia CM, Sherer DM, Spong CY et al. Fetal but not maternal serum cytokine levels correlate with histologic acute placental inflammation. Am J Perinatology 1997; 14: 419-22.
91. Adinolfi A. Infectious diseases and pregnancy, cytokines and neurological impairment: an hypothesis. Dev Med Child Neurol 1993; 35: 549-58.
92. Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol 1993; 35: 549-58.
93. Wu YW, Colford JM. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000; 284: 1417-24.
94. Wu YW. Systemic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002; 8: 25-9.
95. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the premature infant. Pediatr Res 1997; 42: 1-8.
96. Yoon BH, Romero R, Yang SH et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leuko-malacia. Am J Obstet Gynecol 1996; 174: 1433-40.
97. Yoon BH, Romero R, Park JS et al. Fetal exposure to an intraamniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675-81.
98. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44: 665-75.
99. Duggan PJ, Maalouf EF, Watts TL et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001; 358:1699-700.
100. Deguchi K, Mizuguchi M, Takashima S. Immunohistochemical expression of tumor necrosis factor-a in neonatal leukomala-cia. Pediatr Neurol 1996; 14: 13-16.
101. Kadhim H, Tabarki B, Verellen G et al. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001; 56: 1278-84.
102. Rezaie P, Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002; 22: 106-32.
103. Kadhim H, Tabarki B, De Prez C, Sebrire G. Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? Acta Neuropathol 2003; 105:209-16.
104. Gilmore JH, Castillo M, Rojas M. Early onset schizophrenia in a patient with premature birth, germinal matrix hemorrhage and periventricular leukoencephalopathy. Schizophr Res 2000; 44:158-60.
105. Rivkin P, Kraut M, Barta P et al. White matter hyperintensity volume in late-onset and early-onset schizophrenia. Int J Geriatric Psychiatry 2000; 15: 1085-9.
106. Sigmundsson T, Suckling J, Maier M et al. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 2001; 158: 234-43.
107. Kubicki M, Westin C-F, Maier SE et al. Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am J Psychiatry 2002; 159: 813-20.
108. Volpe JJ. Subplate neurons - missing link in brain injury of the premature infant? Pediatrics 1996; 97: 112-3.
109. Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specificity. Arch Gen Psychiatry 1997; 54: 943-52.
110. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65-73.
111. Jarskog LF, Xiao H, Wilkie MB et al. Cytokine regulation of embryonic dopaminergic and serotonergic neuron survival in vitro. Int J Dev Neurosci 1997; 15: 711-6.
112. Marx CE, Jarskog LF, Lauder JM et al. Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol Psychiatry 2001; 50: 743-9.
113. Araujo DM, Cotman CW. Differential effects of interleukin-lb and interleukin-2 on glia and hippocampal neurons in culture. Int J Dev Neurosci 1995; 13: 201-12.
114. Gelbard HA, Dzenko KA, DiLoreto D et al. Neurotoxic effects of tumor necrosis factor in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev Neurosci 1993; 15: 417-22.
115. Chao CC, Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cultures. Dev Neurosci 1994; 16: 171-9.
116. Jeohn GH, Kong LY, Wilson B, Hong J. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 1998; 85: 1-10.
117. Mehler MF, Rozental R, Dougherty M et al. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 1993; 362: 62-5.
118. Munoz-Fernandez MA, Cano E, O’Donnell CA et al. Tumor necrosis factor-a (TNF-a), interferon-y, and interleukin-6 but not TNF-3 induce differentiation of neuroblastoma cells: the role of nitric oxide. Neurochem 1994; 62: 1330-6.
119. Mehler MF, Marmur R, Gross R et al. Cytokines regulate the cellular phenotype of developing neural lineage species. Int J Dev Neurosci 1995; 13: 213-40.
120. Sarder M, Abe K, Saito H, Nishiyama N. Comparative effect of IL-2 and IL-6 on morphology of cultured hippocampal neurons from fetal rat brain. Brain Res 1996; 715: 9-16.
121. Neumann H, Schweigreiter R, Yamashita T et al. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. Neurosci 2002; 22: 854-62.
122. Reichardt LF, Farinas I. Neurotrophic factors and their receptors: roles in neuronal development and function. In: Molecular and Cellular Approaches to Neuronal Development (Cowan WM, Jessell TM, Zipursky SL, eds). New York: Oxford University Press, 1997: 220-63.
123. NTR decide? Neuron 1997; 18: 187-90.
124. Gadient RA, Cron KC, Otten U. Interleukin-13 and tumor necrosis factor-a synergistically stimulate nerve growth factor (NGF) release from cultures rat astrocytes. Neurosci Lett 1990;117:335-40.
125. Juric DM, Carman-Krzan M. Interleukin-13, but not IL-la, mediates nerve growth factor secretion from rat astrocytes via type IIL-1 receptor. Int J Dev Neurosci 2001; 19: 675-83.
126. Heese K, Hock C, Otten U. Inflammatory signals induce neurotrophin expression in human microglia cells. J Neurochem 1998; 70: 699-707.
127. Marz P, Heese K, Dimitriades-Schmutz B et al. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocyte differentiation and neurotrophin expression. Glia 1999;26:191-200.
128. Stadelmann C, Kerschensteiner M, Misgeld T et al. BDNF and gpl45trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 2002; 125: 75-85.
129. Nakajima K, Tohyama Y, Kohsaka S, Kurihara T. Ceramide activates microglia to enhance the production/secretion of brain-derived neurotrophic factor (BDNF) without induction of deleterious factors in vitro. J Neurocbem 2002; 80: 697-705.
130. Shi L, Fatemi SH, Sidewell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003; 23: 297-302.
131. Zuckerman L, Weiner I. Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation. Psychopkarmacol 2003; 169: 308-13.
132. Zuckerman L, Rehavi M, Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacol 2003; 28: 1778-89.
133. Borrell J, Vela JM, Arevalo-Martin A et al. Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia. Neuropsycbo-phartnacol 2002; 26: 204-15.
134. Gatti S, Bartfai T. Induction of tumor necrosis factor-a mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res 1993; 624: 291-4.
135. Laye S, Parnet P, Goujon E, Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol Brain Res 1994; 27: 157-62.
136. Reinisch N, Woikersdorfer M, Kahler C et al. Interleukin-1 receptor type I mRNA in mouse brain as affected by administration of bacterial lipopolysaccharide. Neurosci Lett 1994; 166: 165-7.
137. Konsman JP, Kelly K, Dantzer R. Temporal and spacial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1 beta and inducible nitric oxide synthase in rat brain. Neurosci 1999; 89: 535-48.
138. Quan N, Whiteside M, Herkenham M. Time course and localization patterns of interleukin-lb messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 1998; 83: 281-93.
139. Wong ML, Bongiorno PB, Rettori V et al. Interleukin (IL) 1/3, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in central nervous system and anterior pituitary during systemic inflammations: pathophysiological implications. Proc Nat Acad Sci USA 1997; 94: 227-32.
140. Buttini M, Boddeke H. Peripheral lipopolysaccharide stimulation induces interleukin-113 messenger RNA in rat brain microglial cells. Neuroscience 1995; 65: 523-30.
141. van Dam AM, Bauer J, Tilders FJH, Berkenbosch F. Endotoxin-induced appearance of immunoreactive interleukin-13 in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 1995; 65: 815-26.
142. Buttini M, Limonta S, Boddeke HWGM. Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain. Neurocbem Inti 1996; 29: 25-35.
143. Pitossi F, del Ray A, Kabiersch A, Besedovsky H. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. J Neurosci Res 1997; 48: 287-98.
144. Sacoccio C, Dornand J, Barbanel G. Differential regulation of brain and plasma TNFa produced after endotoxin shock. Neuroreport 1998; 9: 309-13.
145. Quan N, Stern EL, Whiteside MB, Herkenham M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol 1999; 93: 72-80.
146. Ornoy A, Altshuler G. Maternal endotoxemia, fetal anomalies, and central nervous system damage: a rat model of a human problem. Am J Obstet Gynecol 1976; 124: 196-204.
147. Collins JG, Smith MA, Arnold RR, Offenbacher S. Effects of escherichia coli and porphyromonas gingivalis lipopolysaccharide on pregnancy outcome in the golden hamster. Infect Immunity 1994; 62: 4652-5.
148. Fidel PL Jr, Romero R, Wolf N et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994; 170: 1467-75.
149. Schlafer DH, Yuh B, Foley GL et al. Effect of salmonella endotoxin administered to pregnant sheep at 133-142 days gestation on fetal oxygenation, maternal and fetal adrenocorticotropic hormone and cortisol, and maternal plasma tumor necrosis factor a concentrations. Biol Reproduct 1994; 50: 1297-302.
150. Goto M, Yoshioka T, Ravindranath T et al. LPS injected into the pregnant rat late in gestation does not induce fetal endotoxemia. Res Comm Mol Path Pbarm 1994; 85: 109-12.
151. Kijima K, Yoneyama Y, Sawa R, Araki T. Effects of fetal endotoxin administration on plasma prostoglandin F2a and cortisol levels in late-gestation fetal goats. Fetal Diag Therapy 1999; 14: 240-3.
152. Debillon T, Gras-Leguen C, Verielle V et al. Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res 2000; 47: 736-42.
153. Bell MJ, Hallenbeck JM. Effects of intrauterine inflammation on developing rat brain. Neurosci Res 2002; 70: 570-9.
154. Cai Z, Pan Z-L, Pang Y et al. Cytokine induction in fetal rat brain and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000; 47: 64-72.
155. Urakubo A, Jarskog LF, Lieberman JA, Gilmore JH. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizopbr Res 2001; 47: 27-36.
156. Gilmore JH, Jarskog LF, Vadlamudi S. Maternal infection alters BDNF and NGF expression in the fetal and neonatal brain and maternal-fetal unit of the rat. J Neuroimmunol 2003;138:49-55.
157. Cabelli RJ, Hohn A, Shatz CJ. Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF. Science 1995; 267: 1662-6.
158. McAllister AK, Katz LC, Lo DC. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron 1997; 18: 767-78.
159. Turrin NP, Gayle D, Ilyin SE et al. Pro-inflammatory and antiinflammatory cytokine mRNA production in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull 2001; 54: 443-53.
160. Nadeau S, Rivest S. Regulation of the gene encoding tumor necrosis factor alpha (TNF-a) in the rat brain and pituitary in response to different models of systemic immune challenge. J Neuropatbol Exp Neurol 1999; 58: 61-77.
161. Lapchak PA, Araujo DM, Hefti F. Systemic interleukin-13 decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience 1993; 53: 297-301.
162. Adams JM, Heath HD, Imagawa DT et al. Viral infections in the embryo. Am J Dis Child 1956; 92: 109-14.
163. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993; 329: 1246-53.
164. Trejo JL, Machin C, Arahuetes RM, Rua C. Influence of maternal adrenalectomy and glucocorticoid administration on the development of rat cerebral cortex. Anat Etnbryol 1995; 192: 89-99.
165. Koenig JI, Kirkpatrick B, Lee P. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsycho-pharmacol 2002; 27: 309-18.
166. Altshuler G. Some placental considerations related to neurodevelopmental and other disorders. J Child Neurol 1993; 8: 78-94.
167. Butler PD, Susser ES, Brown AS et al. Prenatal nutritional deprivation as a risk factor in schizophrenia: preclinical evidence. Neuropsychopharmacol 1994; 11: 227-35.
168. Upfold JB, Smith MSR. Maternal hyperthermia as a cause of ‘idiopathic’ mental retardation. Med Hypoth 1988; 27: 89-92.